IVF study probes nasal Spray's hidden role in pregnancy support
NCT ID NCT07620067
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how a nasal spray (GnRH agonist) helps support the early stages of pregnancy after IVF. Researchers will measure hormones and other substances in the blood and fluid around the eggs to understand the spray's effects. The study involves 150 women aged 18-45 undergoing their first to third IVF cycle with a fresh embryo transfer.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADMINISTRATION OF HORMONAL LUTEAL SUPPORT are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shaare Zedek Medical Center
RECRUITINGJerusalem, 9103102, Israel
More trials for these conditions
Other studies related to the condition(s) this trial covers.